While awaiting full clinical translation of COL7A1 genetic corrections, our artificial intelligence interrogation, which emphasized the phenotype-endotype association in RDEB adults, suggests that monitoring of immune and inflammatory metabolic states could improve the management of these patients. Here, COL7A1 is linked to recessive dystrophic epidermolysis bullosa.